These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 22811596)

  • 1. The difference in pharmacokinetics and pharmacodynamics between extended-release fluvastatin and immediate-release fluvastatin in healthy Chinese subjects.
    Xu HR; Chen WL; Chu NN; Li XN; Zhu JR
    J Biomed Biotechnol; 2012; 2012():386230. PubMed ID: 22811596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steady-state pharmacokinetics of fluvastatin in healthy subjects following a new extended release fluvastatin tablet, Lescol XL.
    Barilla D; Prasad P; Hubert M; Gumbhir-Shah K
    Biopharm Drug Dispos; 2004 Mar; 25(2):51-9. PubMed ID: 14872552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of treatment with fluvastatin extended-release 80-mg tablets and immediate-release 40-mg capsules in patients with primary hypercholesterolemia.
    Isaacsohn JL; LaSalle J; Chao G; Gonasun L
    Clin Ther; 2003 Mar; 25(3):904-18. PubMed ID: 12852707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and pharmacodynamics of fluvastatin in heart transplant recipients taking cyclosporine A.
    Park JW; Siekmeier R; Lattke P; Merz M; Mix C; Schüler S; Jaross W
    J Cardiovasc Pharmacol Ther; 2001 Oct; 6(4):351-61. PubMed ID: 11907637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of clopidogrel on the steady-state pharmacokinetics of fluvastatin.
    Ayalasomayajula SP; Vaidyanathan S; Kemp C; Prasad P; Balch A; Dole WP
    J Clin Pharmacol; 2007 May; 47(5):613-9. PubMed ID: 17442686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of an extended-release formulation of fluvastatin for once-daily treatment of primary hypercholesterolemia.
    Ballantyne CM; McKenney J; Trippe BS
    Am J Cardiol; 2000 Oct; 86(7):759-63. PubMed ID: 11018196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of gabapentin after a single day and at steady state following the administration of gastric-retentive- extended-release and immediate-release tablets: a randomized, open-label, multiple-dose, three-way crossover, exploratory study in healthy subjects.
    Gordi T; Hou E; Kasichayanula S; Berner B
    Clin Ther; 2008 May; 30(5):909-16. PubMed ID: 18555937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the efficacy and tolerability of fluvastatin extended-release and immediate-release formulations in the treatment of primary hypercholesterolemia: a randomized trial.
    Olsson AG; Pauciullo P; Soska V; Luley C; Pieters RE; Broda G; Palacios B;
    Clin Ther; 2001 Jan; 23(1):45-61. PubMed ID: 11219479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of fluvastatin in subjects with renal impairment and nephrotic syndrome.
    Appel-Dingemanse S; Smith T; Merz M
    J Clin Pharmacol; 2002 Mar; 42(3):312-8. PubMed ID: 11865968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety, tolerability, and pharmacokinetics of an extended-release formulation of fluvastatin administered once daily to patients with primary hypercholesterolemia.
    Sabia H; Prasad P; Smith HT; Stoltz RR; Rothenberg P
    J Cardiovasc Pharmacol; 2001 May; 37(5):502-11. PubMed ID: 11336101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time-of-intake (morning versus evening) of extended-release fluvastatin in hyperlipemic patients is without influence on the pharmacodynamics (mevalonic acid excretion) and pharmacokinetics.
    Fauler G; Abletshauser C; Erwa W; Löser R; Witschital K; März W
    Int J Clin Pharmacol Ther; 2007 Jun; 45(6):328-34. PubMed ID: 17595890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional intestinal absorption and biliary excretion of fluvastatin in the rat: possible involvement of mrp2.
    Lindahl A; Sjöberg A; Bredberg U; Toreson H; Ungell AL; Lennernäs H
    Mol Pharm; 2004; 1(5):347-56. PubMed ID: 16026004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of hydrocodone extended-release tablets formulated with different levels of coating to achieve abuse deterrence compared with a hydrocodone immediate-release/acetaminophen tablet in healthy subjects.
    Darwish M; Bond M; Tracewell W; Robertson P; Yang R
    Clin Drug Investig; 2015 Jan; 35(1):13-22. PubMed ID: 25391549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and tolerability of fluvastatin extended-release delivery system: a pooled analysis.
    Ballantyne CM; Pazzucconi F; Pintó X; Reckless JP; Stein E; McKenney J; Bortolini M; Chiang YT
    Clin Ther; 2001 Feb; 23(2):177-92. PubMed ID: 11293552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and bioequivalence evaluation of two different atorvastatin calcium 10-mg tablets: A single-dose, randomized-sequence, open-label, two-period crossover study in healthy fasted Chinese adult males.
    Liu YM; Pu HH; Liu GY; Jia JY; Weng LP; Xu RJ; Li GX; Wang W; Zhang MQ; Lu C; Yu C
    Clin Ther; 2010 Jul; 32(7):1396-407. PubMed ID: 20678686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and bioequivalence of single dose and multiple doses of immediate- and extended-release formulations of dexibuprofen in healthy Chinese subjects.
    Xu MJ; Zou C; H Chu J; Wu T; Liu SJ; Zhang J; Chen M; Liu F; Xiong NN; Ju WZ; S Tan H
    Int J Clin Pharmacol Ther; 2011 Mar; 49(3):237-46. PubMed ID: 21329626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CYP2C9*3(1075A>C), MDR1 G2677T/A and MDR1 C3435T are determinants of inter-subject variability in fluvastatin pharmacokinetics in healthy Chinese volunteers.
    Zhou Q; Ruan ZR; Yuan H; Zeng S
    Arzneimittelforschung; 2012 Nov; 62(11):519-24. PubMed ID: 22941809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficacy and safety of fluvastatin extended-release tablets in Chinese patients with hyperlipidemia: a multi-center, randomized, double-blind, double dummy, active-controlled, parallel-group study].
    Zhao S; Wang F; Yang K; Hao Y; Li G; Yang M; Yang Z
    Zhonghua Nei Ke Za Zhi; 2014 Jun; 53(6):455-9. PubMed ID: 25146513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose dependency of fluvastatin pharmacokinetics in serum determined by reversed phase HPLC.
    Siekmeier R; Lattke P; Mix C; Park JW; Jaross W
    J Cardiovasc Pharmacol Ther; 2001 Apr; 6(2):137-45. PubMed ID: 11509920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereoselective analysis of fluvastatin in human plasma for pharmacokinetic studies.
    Lanchote VL; Rocha A; de Albuquerque FU; Coelho EB; Bonato PS
    J Chromatogr B Biomed Sci Appl; 2001 Dec; 765(1):81-8. PubMed ID: 11817313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.